Gilead Sciences Inc pharmaceutical company - Filepic
KUALA LUMPUR: A group of more than 50 health-related organisations and individuals is urging American biopharmaceutical company Gilead Sciences to allow Malaysia to import generic versions of remdesivir, an anti-viral drug used to treat Covid-19 patients.
The generic versions of remdesivir, which was originally developed to treat Ebola, are from manufacturers Gilead has given voluntary licensing (VL) agreements to.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
